Back to company

SOPHION BIOSCIENCE A/S: Financial statements 2018

CVR: 10021065

SOPHION BIOSCIENCE A/S (CVR 10021065) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 70,833,000 and a net result of DKK 40,269,000 compared with DKK 17,344,000 the year before. That is an increase of 14% compared with the year before. Equity amounted to DKK 98,251,000. The solvency ratio was 80.3%. The company had 38 employees in the financial year.

Gross Profit
70,833,000 kr.
Profit/Loss
40,269,000 kr.
Equity
98,251,000 kr.
Total Assets
122,401,000 kr.
Employees
38

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-70.8 mio.40.3 mio.98.3 mio.38
2017-62.1 mio.17.3 mio.101.3 mio.41
201670.3 mio.45.6 mio.-17.3 mio.107.2 mio.48
201587.8 mio.56 mio.8.7 mio.124.4 mio.-
201383.4 mio.54 mio.18.3 mio.105.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on SOPHION BIOSCIENCE A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

SOPHION BIOSCIENCE A/S: The 2017 annual report is outApr 10, 2018

SOPHION BIOSCIENCE A/S has published its annual report for 2017. Gross profit came to DKK 62,122,000, and the net result was DKK 17,344,000.

About SOPHION BIOSCIENCE A/S

SOPHION BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Michel Krall Jürgens. The company is owned by Sapphire Bioscience Holding ApS. The company has 41 employees. In 2025, the company reported a gross profit of DKK 102,112,000 and a net result of DKK 4,354,000 compared with DKK 39,127,000 the year before. Equity amounted to DKK 178,418,000.